Het effect van electronisch gegenereerde feedback over reumageneesmiddelen bij patiënten met reumatoïde artritis

INTERVENTION: Patients in the intervention group receive their medication during 1 year in an electronic device. Before each regular (3‐monthly) consult to the rheumatologist, patient's medication adherence will be assessed by reading out the electronic device and (if necessary) possible barriers to medication intake will be discussed with the pharmacist on a semi‐structured way. Patients in the control group will receive standard care (an interview with the pharmacy consultant without electronic drug monitor feedback). CONDITION: ; ; PRIMARY OUTCOME: The difference in proportion of non‐adherence patients (less than 80% medication adherence) after 1 year SECONDARY OUTCOME: Time to low disease activity, time to the first anti‐TNF, the proportion of patients on anti‐TNF therapy and disease activity after 1 year INCLUSION CRITERIA: • newly diagnosed with RA (2010 ARA criteria or clinical judgement rheumatologist) • initiating DMARDS • >18 years • sufficient ability to understand Dutch • be able to be followed for 12 months (life expectancy)